Open call for tenders
Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
Various medicinal products · for IMELDA VZW · Belgium · published in Dutch
What the buyer wants
Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
4 lots
- INFLIXIMAB IV
- TOCILIZUMAB
- DENOSUMAB SC
- EPOËTINE ALFA
Companies that won similar tenders
Companies that won public tenders in the same category (Various medicinal products) since 2024, according to EU award notices. Likely competitors, or partners for a joint offer.
- Myhrabc · Czechia86 wins · last 8 Oct 2026
- pharmos.cz · Czechia27 wins · last 8 Oct 2026
- Eurobio Scientific · France24 wins · last 23 Oct 2026
- lekarna.cz · Czechia17 wins · last 6 Oct 2026
- Adrona · Latvia12 wins · last 8 Jun 2026
- Innovative Diagnostics · France9 wins · last 23 Oct 2026
- Stemcell Technologies · France8 wins · last 5 Jun 2026
- DYNEX TECHNOLOGIES · Czechia7 wins · last 19 Aug 2026
- PentaGen · Czechia6 wins · last 17 Dec 2025
- GeneProof · Czechia5 wins · last 29 Jul 2026
- Labelians · France4 wins · last 2 Oct 2026
- BIOHEM · Slovakia3 wins · last 19 Aug 2026
and 15 more.